COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,223 Articles (22,733 medRxiv, 8,490 bioRxiv)

Most recent first Previous |  Page 862: Articles 8611-8620  | Next

Modifications to student quarantine policies in K-12 schools implementing multiple COVID-19 prevention strategies restores in-person education without increasing SARS-CoV-2 transmission risk, January-March 2021
Dawson, P., Worrell, M. C., Malone, S., Fritz, S. A., McLaughlin, H. P., Montgomery, B. K., Boyle, M., Gomel, A., Hayes, S., Maricque, B., Lai, A. M., Neidich, J. A., Tinker, S. C., Lee, J. S., Orscheln, R. C., Tong, S., Charney, R., Rebmann, T., Mooney, J., Rains, C., Yoon, N., Petit, M., Towns, K., Goddard, C., Schmidt, S., Barrios, L. C., Neatherlin, J. C., Salzer, J. S., Newland, J. G., COVID-19 Response Fieldwork and Laboratory Teams AND Missouri School District Data and Coordination
10.1101/2022.03.18.22272631 — Posted: 2022-03-21
A 16-Month Longitudinal Investigation of Risk and Protective Factors for Mental Health Outcomes Throughout Three National Lockdowns and a Mass Vaccination Campaign: Evidence from a Weighted Israeli Sample During COVID-19
Hertz-Palmor, N., Ruppin, S., Matalon, N., Mosheva, M., Dorman-Ilan, S., Avinir, A., Mekori-Domachevsky, E., Hasson-Ohayon, I., Gross, R., Gothelf, D., Pessach, I.
10.1101/2022.03.18.22272624 — Posted: 2022-03-21
Robust and durable prophylactic protection conferred by RNA interference in preclinical models of SARS-CoV-2
Anglero-Rodriguez, Y. I., Lempp, F. A., McIninch, J., Schlegel, M. K., Brown, C. R., Foster, D. J., Castoreno, A. B., Nguyen, T., Subramanian, M., Montiel-Ruiz, M., Kaiser, H., Sahakyan, A., Spreafico, R., Morskaya, S. S., Barry, J. D., Berman, D., Lefebvre, S., Kasper, A., Racie, T., Weddle, D., Mobley, M., Rogers, A., Dybowski, J., Chong, S., Nair, J., Simon, A., Sloan, K., Hwang, S., Virgin, H. W., Fitzgerald, K., Maier, M. A., Hinkle, G., Hebner, C., Akinc, A., Jadhav, V.
10.1101/2022.03.20.485044 — Posted: 2022-03-21
Stability and expression of SARS-CoV-2 spike-protein mutations
Baek, K. T., Mehra, R., Kepp, K. P.
10.1101/2022.03.21.485157 — Posted: 2022-03-21
Multi-organ impairment and Long COVID: a 1-year prospective, longitudinal cohort study
Dennis, A., Cuthbertson, D. J., Wootton, D., Crooks, M., Gabbay, M., Eichert, N., Mouchti, S., Pansini, M., Roca-Fernandez, A., Thomaides-Brears, H., Kelly, M., Robson, M., Hishmeh, L., Attree, E., Heightman, M. J., Banerjee, R., Banerjee, A.
10.1101/2022.03.18.22272607 — Posted: 2022-03-21
15-month follow-up of anti-spike receptor binding domain (RBD) SARS-CoV-2 antibodies among healthcare workers in Boston, MA
Dodge, M. C., Cole, M., Duffy, E. R., Werler, M. M., Kataria, Y.
10.1101/2022.03.18.22272553 — Posted: 2022-03-21
Herpesvirus Reactivations in Critically-Ill COVID-19 Patients with Autoantibodies Neutralizing Type I Interferons
Busnadiego, I., Abela, I. A., Frey, P. M., Hofmaenner, D. A., Scheier, T. C., Schuepbach, R. A., Buehler, P. K., Brugger, S. D., Hale, B. G.
10.1101/2022.03.19.22272532 — Posted: 2022-03-21
SARS-CoV-2 Omicron spike H655Y mutation is responsible for enhancement of the endosomal entry pathway and reduction of cell surface entry pathway
Yamamoto, M., Tomita, K., Hirayama, Y., Inoue, J.-i., Kawaguchi, Y., Gohda, J.
10.1101/2022.03.21.485084 — Posted: 2022-03-21
Immune and Clotting Dysfunction Detected in Saliva and Blood Plasma after COVID-19.
Jang, H., Choudhury, S., Yu, Y., Sievers, B. L., Gelbart, T., Singh, H., Rawlings, S. A., Tan, G. S., Smith, D., Freire, M.
10.1101/2022.03.18.484814 — Posted: 2022-03-21
SARS-CoV-2 spike proteins uptake mediated by lipid raft ganglioside GM1 in human cerebrovascular cells
McQuaid, C., Solorzano, A., Dickerson, I., Deane, R.
10.1101/2022.03.20.485050 — Posted: 2022-03-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).